Insmed Incorporated

BMV:INSM * Stock Report

Market Cap: Mex$63.8b

Insmed Management

Management criteria checks 2/4

Insmed's CEO is Will Lewis, appointed in Sep 2012, has a tenure of 11.5 years. total yearly compensation is $7.79M, comprised of 9.4% salary and 90.6% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth MX$184.59M. The average tenure of the management team and the board of directors is 4.3 years and 9.8 years respectively.

Key information

Will Lewis

Chief executive officer

US$7.8m

Total compensation

CEO salary percentage9.4%
CEO tenure11.5yrs
CEO ownership0.3%
Management average tenure4.3yrs
Board average tenure9.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Will Lewis's remuneration changed compared to Insmed's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

Compensation vs Market: Will's total compensation ($USD7.79M) is above average for companies of similar size in the MX market ($USD1.47M).

Compensation vs Earnings: Will's compensation has increased whilst the company is unprofitable.

CEO

Will Lewis (54 yo)

11.5yrs

Tenure

US$7,789,898

Compensation

Mr. William H. Lewis, also known as Will, J.D., M.B.A., serves as Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January, 2024. He has been Chief Executive Officer and President at...

Leadership Team

NamePositionTenureCompensationOwnership
William Lewis
President11.5yrsUS$7.79m0.29%
MX$ 184.6m
Sara Bonstein
Chief Financial Officer4.2yrsUS$3.43m0.0035%
MX$ 2.2m
Roger Adsett
Chief Operating Officer4.3yrsUS$4.64m0.040%
MX$ 25.4m
John Wise
Chief Commercial Officer4.3yrsUS$4.02m0.030%
MX$ 18.9m
Martina Flammer
Chief Medical Officer4.3yrsUS$3.76m0.0041%
MX$ 2.6m
Brian Kaspar
Chief Scientific Officerno datano datano data
Eleanor Barisser
Associate Director of Investor Relationsno datano datano data
Michael Smith
Chief Legal Officer & Corporate Secretary2.7yrsno data0.058%
MX$ 37.1m
Mandy Fahey
Executive Director of Corporate Communicationsno datano datano data
S. Schaeffer
Chief People Strategy Officer11.2yrsUS$2.66m0.025%
MX$ 15.8m
Eugene Sullivan
Chief Product Strategy Officer6.8yrsUS$1.69mno data
Neil Hughes
GM & Head of Europe4.8yrsno datano data

4.3yrs

Average Tenure

54yo

Average Age

Experienced Management: INSM *'s management team is considered experienced (4.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
William Lewis
President11.5yrsUS$7.79m0.29%
MX$ 184.6m
David W. McGirr
Independent Director10.4yrsUS$320.00k0.049%
MX$ 31.2m
Melvin Sharoky
Independent Director22.8yrsUS$312.50k0.22%
MX$ 138.2m
Alfred Altomari
Independent Director11.6yrsUS$312.70k0.029%
MX$ 18.5m
David Brennan
Lead Independent Director9.8yrsUS$342.30k0.064%
MX$ 41.1m
Clarissa Desjardins
Independent Director4.3yrsUS$315.00k0.024%
MX$ 15.3m
Elizabeth Anderson
Independent Director5.3yrsUS$310.00k0.029%
MX$ 18.2m
Leo Lee
Independent Director5.8yrsUS$315.00k0.066%
MX$ 42.2m
Carol Schafer
Independent Director3.9yrsUS$315.00k0.021%
MX$ 13.7m

9.8yrs

Average Tenure

64yo

Average Age

Experienced Board: INSM *'s board of directors are considered experienced (9.8 years average tenure).